We engineered loss of FZD9 in two HBEC cell lines and found changes in EMT genes that had previously been associated with FZD9 negative NSCLC cell lines, suggesting that persistence of early changes may contribute to lesion progression (9). The gene discussed is FZD9; the disease is non-small cell lung carcinoma.